Drug Pricing in the United States
JULY 14, 2018
1 Pharmaceutical companies are unique in their capacity, due to little regulation and oversight, to raise prices. Because of the ability of health insurance companies and benefit executives at leading pharmaceutical companies to negotiate discounts and benefit packages, many in the industry argue that list prices on prescription drugs aren’t actually a reliable indicator of what Americans pay. In order to limit competition, pharmaceutical companies rely heavily on patent laws.